Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE Platform for the Treatment of Paroxysmal Atrial Fibrillation
Diagnostic and Interventional Cardiology,
View(active tab) Edit Delete Revisions Entityqueue Devel News | Atrial Fibrillation | March 28, 2024 Findings from the admIRE…